{"text": ["AbbVie", "(ABBV)", "Gains", "But", "Lags", "Market:", "What", "You", "Should", "Know"], "created_at": "2020-04-22 21:45:09"}
{"text": ["Were", "Hedge", "Funds", "Right", "About", "AbbVie", "Inc", "(ABBV)?"], "created_at": "2020-04-22 18:21:56"}
{"text": ["Healthcare", "ETFs", "Looks", "Strong", "Ahead", "of", "Q1", "Earnings"], "created_at": "2020-04-22 14:55:02"}
{"text": ["Form", "8.3", "-", "Abbvie", "Inc", "-", "Amendment"], "created_at": "2020-04-22 14:27:00"}
{"text": ["Form", "8.3", "-", "ABBVIE", "INC"], "created_at": "2020-04-22 11:49:00"}
{"text": ["AbbVie", "Gets", "FDA", "Nod", "for", "Imbruvica+Rituxan", "in", "First-Line", "CLL"], "created_at": "2020-04-22 11:46:11"}
{"text": ["Form", "8.3", "-", "AbbVie", "Inc."], "created_at": "2020-04-22 10:21:00"}
